Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

Rodger McEver

Oklahoma Medical Research Foundation, Department: Na

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

Novartis AG

Disclosed Value
Listed Reason
Intellectual property rights (e.g., royalties, patents, copyrights) not from the awardee Institution

Novartis AG is developing an antibody-based therapeutic for treating sickle cell disease. This humanized antibody to P-selectin to treat vasoocclusion in sickle cell disease is based, in part, on discoveries made by Dr. McEver. Dr. McEver’s NIH-funded research continues to study how selectins bind to ligands. Through analysis of his work, the Oklahoma Medical Research Foundation (OMRF) has determined that findings in his lab could affect the progression of Novartis' antibody-based through clinical trials and, ultimately, the product’s sales, which could potentially trigger certain milestone payments to Dr. McEver from Novartis.

Listed Research Project
Platelet CLEC-2 regulation of vascular integrity during inflammation

Sepsis is a common and often lethal illness that results from bacterial entry into the bloodstream. Most patients have severe complications, even if antibiotics eliminate the bacteria, because of an excessive inflammatory response. One major complication is widespread leakage of fluid from blood vessels into the surrounding tissues, which can cause shock and organ failure. This study addresses the hypothesis that leakage occurs in blood vessels called venules and that blood cells (leukocytes and platelets) can augment and/or limit leakage by specific mechanisms. The study may reveal new strategies to treat blood-vessel leakage in patients with sepsis.

Filed on March 14, 2017.

Tell us what you know about Rodger McEver's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

Name Institution Type Company Disclosed Value
Rodger D. McEver Oklahoma Medical Research Foundation Conflict of Interest Selexys Pharmaceuticals >$600,000
Rodger McEver Oklahoma Medical Research Foundation Conflict of Interest Novartis AG >$600,000
Rodger McEver Oklahoma Medical Research Foundation Conflict of Interest Novartis AG >$600,000
Rodger McEver Oklahoma Medical Research Foundation Conflict of Interest Tetherex Pharmaceuticals $20,000 - $39,999
Rodger McEver Oklahoma Medical Research Foundation Conflict of Interest Tetherex Pharmaceuticals $20,000 - $39,999
Rodger McEver Oklahoma Medical Research Foundation Conflict of Interest Tetherex Pharmaceuticals $20,000 - $39,999
If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page